Category: Health Care News
New Jersey has become the epicenter of a new revolution in the medical community to develop innovative cures to a deadly disease that takes the lives of more than a half a million Americans every year: cancer. According to Yahoo.com and the Thomara Latimer Cancer Foundation 564,800 Americans succumb to the disease each year. Among those lost from cancer are patients who were diagnosed with cancers that are difficult to fight because they tend to be rare or they do not respond to the existing therapies and treatments that the medical community has developed to fight cancer. Fortunately there are researchers who have backgrounds in both the practice and study of cancer medicine that are leveraging their skills and a unique approach to cancer treatment to develop vital research that could improve the prospects of people that are diagnosed with cancer.
The Rutgers Cancer Institute of New Jersey is on its way to making vital advancement in the worlds of cancer research and cancer treatment. The Institute as described by the NY Times is notable for being among a small group of medical centers that used genomic science to carry out gene sequencing on tumors and to use the practice of genomic sequencing as part of a paradigm known as precision medicine. According to the National Library of Medicine precision medicine is exactly what it sounds like. It is a treatment approach that considers the specificity of factors like genetics (among others) when determining which treatments would be best for a patient. The method allows doctors to use genomic science to be as precise as possible when treating cancer patients.
The work of the New Brunswick-based cancer organization is line with the city’s endeavors to be set apart from its peers as the “Healthcare City.” The Institute’s work received a major boost nearly two years ago when, as noted by Newswise, local man Omar Boraie donated $1.5 million to the development of an endowed chair at the Institute that would be dedicated to the work the organization has done on genomic science’s applications to cancer treatment. The position is known as the Omar Boraie Chair in Genomic Science and it is filled by noted cancer researcher Shridar Ganesan who holds a medical degree and a doctorate. According to Dr. Ganesan cancer is actually “a collection of diseases” that have distinctive characteristics that must be accounted for. Ganesan’s approach to the disease is to go beyond categorizing it according to the part of the body that it develops in and involves using the Institute’s distinctive approach to giving the cancers they examine more precise categorizations that can point toward more treatment plans that are better adapted to a patient’s needs.